The dimerized S100A11 acquires the capacity to promote chondrocyte activation through the p38/MAPK pathway, which then accelerates the development of osteoarthritis (Cecil et al., 2005; Cecil and Terkeltaub, 2008; Figure 6). The gene discussed is S100A11; the disease is osteoarthritis.